colon cancer therapy (NCI)

N/A

Report date: 2025/01/15 20:00:32
NME

Base Information

Drug Namecolon cancer therapy (NCI)
Drug Alias Namecolon cancer therapy, NCIbis-imidazoacridone
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA modulators
TargetsDNA
Therapy Area/IndicationsColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsColonic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A